chr19-50289626-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001145809.2(MYH14):​c.4943G>A​(p.Arg1648Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000646 in 1,610,186 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000049 ( 0 hom. )

Consequence

MYH14
NM_001145809.2 missense

Scores

1
1
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 7.63

Publications

0 publications found
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]
MYH14 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 4A
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.020100325).
BP6
Variant 19-50289626-G-A is Benign according to our data. Variant chr19-50289626-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 164200.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000217 (33/152188) while in subpopulation AMR AF = 0.00209 (32/15278). AF 95% confidence interval is 0.00152. There are 0 homozygotes in GnomAd4. There are 26 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 33 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH14NM_001145809.2 linkc.4943G>A p.Arg1648Lys missense_variant Exon 35 of 43 ENST00000642316.2 NP_001139281.1
MYH14NM_001077186.2 linkc.4844G>A p.Arg1615Lys missense_variant Exon 34 of 42 NP_001070654.1
MYH14NM_024729.4 linkc.4820G>A p.Arg1607Lys missense_variant Exon 33 of 41 NP_079005.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH14ENST00000642316.2 linkc.4943G>A p.Arg1648Lys missense_variant Exon 35 of 43 NM_001145809.2 ENSP00000493594.1

Frequencies

GnomAD3 genomes
AF:
0.000217
AC:
33
AN:
152188
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00209
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000268
AC:
65
AN:
242706
AF XY:
0.000197
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00192
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000487
AC:
71
AN:
1457998
Hom.:
0
Cov.:
32
AF XY:
0.0000400
AC XY:
29
AN XY:
724996
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33410
American (AMR)
AF:
0.00158
AC:
70
AN:
44290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26056
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39588
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85604
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52716
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5302
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1110812
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000217
AC:
33
AN:
152188
Hom.:
0
Cov.:
32
AF XY:
0.000350
AC XY:
26
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41440
American (AMR)
AF:
0.00209
AC:
32
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68032
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.519
Heterozygous variant carriers
0
2
4
7
9
11
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000341
Hom.:
0
Bravo
AF:
0.000181
ExAC
AF:
0.000148
AC:
18

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Oct 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 10, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
Apr 12, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Arg1648Lys in exon 35 of MYH14: This variant is not expected to have clinical significance due to a lack of conservation across species, including mammals. O f note, wallaby has a lysine (Lys) at this position despite high nearby amino ac id conservation. It has been identified in 0.2% (16/7328) of Latino chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
21
DANN
Benign
0.85
DEOGEN2
Benign
0.0
.;.;.;T;.;.;T
Eigen
Benign
-0.36
Eigen_PC
Benign
-0.13
FATHMM_MKL
Benign
0.75
D
LIST_S2
Benign
0.0
.;D;D;D;.;D;.
M_CAP
Benign
0.039
D
MetaRNN
Benign
0.020
T;T;T;T;T;T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
0.0
.;.;.;N;.;.;N
PhyloP100
7.6
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
0.0
.;.;N;.;.;.;.
REVEL
Benign
0.0
Sift
Pathogenic
0.0
.;.;T;.;.;.;.
Sift4G
Benign
1.0
T;T;T;T;.;T;T
Vest4
0.18
ClinPred
0.12
T
GERP RS
2.9
Varity_R
0.10
gMVP
0.16
Mutation Taster
=88/12
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727503228; hg19: chr19-50792883; COSMIC: COSV51832106; API